Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: The Treatment-Naive Microbiome in New-Onset Crohn s Disease

PROVIDER: PRJEB13679 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR1368880.fastq.gz	Fastqsanger.gz
	ERR1368890.fastq.gz	Fastqsanger.gz
	ERR1368900.fastq.gz	Fastqsanger.gz
	ERR1368910.fastq.gz	Fastqsanger.gz
	ERR1368920.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 1359

Similar Datasets

Project description:The Treatment-Naive Microbiome in New-Onset Crohn`s Disease

| PRJEB13680 | ENA

DNA methylation of purified intestinal epithelial cells from treatment-naive paediatric IBD patients and controls

Project description:'Illumina Infinium HumanMethylation450 BeadChip data from CD326+ sorted colonic epithelial cells of mucosal biopsies from treatment-naive paediatric IBD patients (Crohn''s Disease or Ulcerative Colitis) or age-matched controls AC= ascending colon, PSC=sigmoid colon'

2015-09-15 | E-MTAB-3709 | biostudies-arrayexpress

Proteome profiling of cultivated Echerichia coli isolates from Crohn's disease patients

Project description:One of the dysbioses often observed in CD patients is an increased abundance of Escherichia coli (10-100 fold compared to healthy individuals) [Gevers et al., 2014]. E. coli isolates collected from CD and healthy patients were cultivated on LB medium at aerobic conditions up to medium log phase and their total proteomes were analysed by shotgun proteomics by HPLC-MS/MS. Refs. Gevers D, Kugathasan S, Denson LA, Vazquez-Baeza Y, Van Treuren W, Ren B, et al. The treatment-naive microbiome in new-onset Crohn’s disease. 2014. Cell Host Microbe 15: 382–92.

2019-08-15 | PXD010920 | Pride

Project description:Gut microbiome in new onset Crohns Disease

| PRJNA1216747 | ENA

Homo sapiens

Project description:Long ncRNA Landscape in the Ileum of Treatment Naïve Early Onset Crohn Disease

| PRJNA371496 | ENA

Age-of-Onset Dependent Immune maturation in Pediatric Crohn Disease

Project description:Purpose: To clarify the biological processes underlying variation in disease location and antimicrobial sero-reactivity across age-of onset in pediatric Crohn disease. Methods: We characterize the ileal global pattern of gene expression using single-end, 50bp RNA-sequencing using the Illumina HiSeq2000 in 304 treatment-naïve pediatric Crohn patients and non-IBD controls. Reads were quantified using Kallisto with Gencodev23 annotations. For all analyses, data were stratified by patient age-of-onset. Results: Performing differential analysis of all reasonably-expressed transcripts (TPM>5 in ≥5 samples, with significance defined as FDR-corrected p-value<0.05 and fold change≥1.5), we identify a robust gene signature with higher expresison of an immune gene set in older patients (≥10 years at diagnosis) compared to younger patients (<10 years at diagnosis), and a decrease in expression of antimicrobial Paneth cell-derived α-defensins. Conclusion: We provide evidence for maturation of mucosal Th1 immune response and loss of epithelial antimicrobial α-defensins with increasing age-of-onset.

2018-08-01 | GSE101794 | GEO

Project description:Total RNAseq Transcriptome from Ileal and Rectal Biopsy in Treatment Naive Pediatric Crohn Disease

| PRJNA1251616 | ENA

Project description:Shotgun metagenomics of treatment-naive rheumatoid arthritis (RA) patients with new-onset RA.

| PRJNA896336 | ENA

Homo sapiens

Project description:Age-of-Onset Dependent Immune maturation in Pediatric Crohn Disease

| PRJNA395561 | ENA

Diet and multi-omics characterization in the Study of Urban and Rural Crohn Disease Evolution (SOURCE) cohort

Project description:The Study Of Urban and Rural Crohn disease Evolution (SOURCE, n=380) characterized exposures, diet, and host and microbial factors in rural and urban Chinese controls and newly diagnosed Crohn Disease (CD), and in treatment-naïve Israeli CD and controls. We considered diet-omics domains simultaneously to detect complex interactions in the gut to prioritize potential beneficial and pathogenic factors.

2024-02-15 | GSE233900 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data